Page 20 - 南京医科大学学报自然科学版
P. 20

第43卷第3期
               ·310 ·                            南 京    医 科 大 学 学         报                        2023年3月


              LINC01518 的表达可正向提升 IL⁃17 诱导 H1299 细                    Am J Cancer Res,2021,11(4):1572-1585
              胞增殖的能力。                                           [9] CHENG G,LI Y,LIU Z,et al. LncRNA PSMA3⁃AS1 pro⁃
                  LncRNA调控细胞生物学行为的机制之一是其                             motes the progression of non ⁃ small cell lung cancer
              能吸附miRNA影响靶基因的表达,故其在肿瘤等疾                               through targeting miR⁃ 17⁃5p/PD⁃L1[J]. Adv Clin Exp
                                                                     Med,2021,30(10):1043-1050
              病的发生与发展中发挥了重要作用                 [8-10,12-13,15-18] 。由
                                                                [10] XING Z,ZHANG Z,GAO Y,et al. The lncRNA
              于 LINC01518 可竞争结合某些 miRNA 来影响细胞
                                                                     LINC01194/miR ⁃ 486 ⁃ 5p axis facilitates malignancy in
              的某些病变     [12-13] ,故设想在 NSCLC 发病和进展过程
                                                                     non⁃small cell lung cancer via regulating CDK4[J]. Onco
              中,LINC01518 的表达上调或许也能通过结合相应                            Targets Ther,2020,13:3151-3163
              的miRNA促进IL⁃17诱导的肿瘤细胞增殖反应。不                        [11] WANG W W,WEI C G,LI P,et al. Integrative analysis of
              过,这一推测还有待后续进一步对 LINC01518 的细                           mRNA and lncRNA profiles identified pathogenetic
              胞定位和功能研究等加以验证。                                         lncRNAs in esophageal squamous cell carcinoma[J].
                                                                     Gene,2018,661:169-175
             [参考文献]
                                                                [12] ZHANG D H,ZHANG H F,WANG X L,et al. LINC01518
             [1] HERBST R S,MORGENSZTERN D,BOSHOFF C. The            knockdown inhibits tumorigenicity by suppression of
                   biology and management of non small cell lung cancer  PIK3CA/Akt pathway in oesophageal squamous cell carci⁃
                  [J]. Nature,2018,553(7689):446-454                 noma[J]. Artif Cells Nanomed Biotechnol,2019,47(1):
             [2] RICE S J,LIU X,ZHANG J H,et al. Advanced NSCLC      4284-4292
                   patients with high IL⁃ 6 levels have altered peripheral T  [13] KONG N,BAO Y,ZHAO H,et al. Long noncoding RNA
                   cell population and signaling[J]. Lung Cancer Amster⁃  LINC01518 modulates proliferation and migration in TGF⁃
                   dam Neth,2019,131:58-61                           β1⁃treated human tenon capsule fibroblast cells through
             [3] KWIECIEN I,STELMASZCZYK⁃EMMEL A,POLUBIEC⁃           the regulation of hsa⁃miR⁃216b⁃5p[J]. Neuromolecular
                   KOWNACKA M,et al. Elevated regulatory T cells,sur⁃  Med,2022,24(2):88-96
                   face and intracellular CTLA⁃4 expression and interleukin⁃  [14] YOJIRO K,NATSUMI M,TAKAHIRO W,et al. OIP5 ⁃
                   17 in the lung cancer microenvironment in humans[J].  AS1 promotes proliferation of non⁃small⁃cell lung cancer
                   Cancer Immunol Immunother,2017,66(2):161-170      and head and neck squamous cell carcinoma cells[J].
             [4] WANG B,ZHAO C H,SUN G,et al. IL⁃17 induces the      Cancer Genom Proteom,2021,18(4):543-548
                   proliferation and migration of glioma cells through the ac⁃  [15] PENG X,WEI F,HU X. Long noncoding RNA DLGAP1⁃
                   tivation of PI3K/Akt1/NF⁃κB⁃p65[J]. Cancer Lett,2019,  AS1 promotes cell proliferation in hepatocellular carcino⁃
                   447:93-104                                        ma via sequestering miR ⁃ 486 ⁃ 5p[J]. J Cell Biochem,
             [5] XIANG T,LONG H,HE L,et al. Interleukin⁃17 produced  2020,121(2):1953-1962
                   by tumor microenvironment promotes self ⁃ renewal of  [16] CHEN W H,WANG L F,LI X Y,et al. LncRNA SNHG17
                        +
                   CD133 cancer stem⁃like cells in ovarian cancer[J]. On⁃  regulates cell proliferation and invasion by targeting miR⁃
                   cogene,2015,34(2):165-176                         338⁃3p/SOX4 axis in esophageal squamous cell carcinoma
             [6] ZHAO C,LI Y,ZHANG W,et al. IL17 induces NSCLC      [J]. Cell Death Dis,2021,12(9):806
                   A549 cell proliferation via the upregulation of HMGA1,  [17] WANG J,YU Z Y,WANG J,et al. LncRNA NUTM2A⁃
                   resulting in an increased cyclin D1 expression[J]. Int J  AS1 positively modulates TET1 and HIF⁃1A to enhance
                   Oncol,2018,52(5):1579-1592                        gastric cancer tumorigenesis and drug resistance by spong⁃
             [7] GE B H,ZHANG X,ZHOU W,et al. LINC00265 promotes     ing miR⁃376a[J]. Cancer Med,2020,9(24):9499-9510
                   metastasis and progression of hepatocellular carcinoma by  [18] YANG Y,YU Q,LI B,et al. BBOX1⁃AS1 accelerates gas⁃
                   interacting with E2F1 at the promoter of CDK2[J]. Cell J,  tric cancer proliferation by sponging miR⁃3940⁃3p to up⁃
                   2022,24(6):294-301                                regulate BIRC5 expression[J]. Dig Dis Sci,2021,66(4):
             [8] ZHENG G L,LIU Y L,YAN Z X,et al. Elevated LOXL2     1054-1062
                   expression by LINC01347/miR⁃328⁃5p axis contributes to                 [收稿日期] 2022-07-29
                   5 ⁃ FU chemotherapy resistance of colorectal cancer[J].                     (本文编辑:陈汐敏)
   15   16   17   18   19   20   21   22   23   24   25